My HPRA: Register

MAVIRET (PREVIOUSLY ABT-493/ABT-530)

100/40 Milligram Film Coated Tablet

AbbVie LtdEU/1/17/1213/001

Main Information

Trade NameMAVIRET (PREVIOUSLY ABT-493/ABT-530)
Active SubstancesGLECAPREVIR
PIBRENTASVIR
Strength100/40 Milligram
Dosage FormFilm Coated Tablet
Licence HolderAbbVie Ltd
Licence NumberEU/1/17/1213/001

Group Information

ATC CodeJ05AX Other antivirals

Status

Authorised/WithdrawnAuthorised
Licence Issued26/07/2017
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print